NovaQuest Capital buys CutisPharma

CutisPharma Inc said March 26 that it has been sold to NovaQuest Capital Management LLC. Financial terms weren’t announced. Goldman Sachs Specialty Lending Group provided financing. CutisPharma, a Wilmington, Massachusetts specialty pharmaceutical company, develops and commercializes unit-of-use kits, under the FIRST® Kit brand, to help pharmacists in compounding prescriptions. TAP Advisors acted as financial adviser to CutisPharma.

DealsNorth AmericaUSBriefs